Redesign Health
VC Fund
New York, United States
Redesign Health is a company that powers innovation in healthcare by developing technologies, tools, and insights that lower the barriers to change across the industry. Since 2018, exceptional founders have built over two dozen companies at Redesign Health, impacting more than ten million lives across many aspects of the healthcare ecosystemincluding cancer care, teleradiology, COVID-19 testing, metabolic health, and more.
- Total investments:
- 43
- Last investment:
- Lead investor:
- 42%
- Fund size:
- $175M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Redesign Health invests in
Stages Redesign Health invests in
Countries Redesign Health invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 16 contacts → | |||
Investment Focus
Industry
- Health Care 25 (58%)
- Wellness 7 (16%)
- Medical 6 (14%)
- Financial Services 5 (12%)
- Artificial Intelligence 5 (12%)
Stage
- Seed 23 (53%)
- Series A 7 (16%)
- Pre-Seed 4 (9%)
- Series B 4 (9%)
- Venture - Series Unknown 3 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brenda Schmidt
Head of Strategic Partnerships
|
Head of Strategic Partnerships | Total investments: 0 | Find email | |
Brendhan Green
Head of Strategic Partnerships
|
Head of Strategic Partnerships | Total investments: 0 | Find email | |
Brett Shaheen
Chief Executive Officer
|
Chief Executive Officer | Total investments: 0 | Find email | |
Juhi Kabra
Chief of Staff
|
Chief of Staff | Total investments: 0 | Find email | |
Kyle Tatz
Head of New Ventures
|
Head of New Ventures | Total investments: 1 | Find email | |
| See all 16 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Omics Bank is a research oriented healthcare firm that provides platform for drug development, and clinical trials. | $2.3M / Seed / Aug 25, 2026 | ||
| Anomaly is pioneering a new paradigm in healthcare—Precision Payments—to improve payment accuracy and streamline payments for payers and providers, a $300B+ problem. | $17M / Venture - Series Unknown / May 13, 2026 | ||
| Gravity Rail an innovative new platform that enables healthcare organizations to build and manage their own AI-powered engagement workflows. | $2.8M / Seed / Apr 23, 2026 | ||
| Worki.ai is a healthcare workforce infrastructure company that provides an AI-driven platform to help health systems manage. | $2.8M / Pre-Seed / Apr 16, 2026 | ||
| Thrivory is a fintech company helping medical practices get paid faster by advancing funds on their insurance claims. Our AI platform is trained on over 40 billion claims and can predict claim denials, expected reimbursement amounts, and payment timelines with 98% accuracy. We help healthcare providers access the cash they have already earned byadvancing funds on insurance claims, reducing the impact of delayed reimbursements. Our model is fast, flexible, and non-recourse, giving practices the working capital they need to cover payroll, grow operations, or invest in new services. Thrivory serves independent clinics, infusion centers, and specialty practices with tailored working lines that match their unique cash flow cycles. | $3.5M / Seed / Nov 18, 2025 | ||
| Corvus is an AI-powered platform designed to expedite the surgical consultation process, ensuring that the appropriate patients receive the right care at the right time. | Seed / Oct 29, 2025 | ||
| Translucent AI develops an AI-powered financial platform tailored for healthcare operators. The system automates financial reporting, consolidates data from various service lines, and provides real-time insights to support decision-making. It integrates with existing financial systems to streamline operations and reduce reliance on manualprocesses. The platform is designed to handle complex healthcare financial workflows and is built with security and compliance in mind. Translucent AI aims to enhance financial transparency and operational efficiency for healthcare organizations. | $7M / Seed / Aug 06, 2025 | ||
| Noma Therapy is a leading provider of at-home ketamine-assisted psychotherapy, offering an innovative and accessible approach to treating difficult-to-treat depression, anxiety, and PTSD through our comprehensive 16-week program that combines guided ketamine treatment, one-on-one talk therapy, and expert medication management. | $4.3M / Seed / Apr 30, 2025 | ||
| TrampolineAI uses machine learning and generative AI to free up agents' time to focus on members' needs, deliver deep business insights, generate great member experiences, and cut expenses. | Pre-Seed / Mar 27, 2025 | ||
| Vitalic Health is dedicated to improving the well-being of older individuals by focusing on their physical, mental, and emotional health. | $4M / Seed / Dec 20, 2024 | ||
| See all 43 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Redesign Health invest in?
Redesign Health invests primarily in Health Care, Wellness and Medical startups, most often at Seed and Series A stage. Most of the 43 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Redesign Health?
Public channels for Redesign Health include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Redesign Health?
The team at Redesign Health includes Brenda Schmidt (Head of Strategic Partnerships), Brendhan Green (Head of Strategic Partnerships) and Brett Shaheen (Chief Executive Officer), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
